Cephalexin Allergy Testing and Management

Introduction to Cephalexin Administration

The American Academy of Allergy, Asthma, and Immunology recommends that patients without any prior cephalosporin allergy history can receive cephalexin by direct challenge or full therapeutic dose without any testing, as skin testing with cephalexin has "no clear utility" in clinical practice, with a strength of evidence based on clinical guidelines 1
Patients with no history of cephalosporin allergy can be administered cephalexin directly, unless they have a history of anaphylaxis to another cephalosporin, according to the American Academy of Allergy, Asthma, and Immunology 2, 1

The American Academy of Allergy, Asthma, and Immunology states that if a patient has a history of anaphylactic penicillin allergy, cephalexin should be avoided entirely without testing due to a 12.9% cross-reactivity rate, with a high strength of evidence based on clinical studies 3
Cephalexin, along with other aminocephalosporins, shares an identical R1 side chain with aminopenicillins, resulting in a cross-reactivity rate of 16.45% (95% CI: 11.07-23.75) in patients with proven penicillin allergy, according to the American Academy of Allergy, Asthma, and Immunology 2, 3

Skin testing to cephalexin is only advisable in highly specific circumstances, such as patients with multiple documented drug allergies or significant anxiety about receiving the medication, with a moderate strength of evidence based on clinical guidelines 2, 1, 4
If skin testing is deemed necessary, a stepwise approach should be used, starting with epicutaneous/prick testing at 200 mg/mL, followed by intradermal testing at 2.0 mg/mL and 20 mg/mL, with a low strength of evidence due to limited validation of cephalexin skin testing 2
The American Academy of Allergy, Asthma, and Immunology recommends considering penicillin skin testing first to confirm the allergy, followed by an oral amoxicillin challenge to delabel the penicillin allergy, if cephalexin is specifically needed in a patient with anaphylactic penicillin allergy, with a high strength of evidence based on clinical studies 1, 4, 3

The preferred strategy is to select a different cephalosporin with a dissimilar R1 side chain (such as cefazolin, ceftriaxone, or cefepime), which can be given directly without any testing, according to the American Academy of Allergy, Asthma, and Immunology, with a high strength of evidence based on clinical guidelines 3
The American Academy of Allergy, Asthma, and Immunology recommends avoiding routine skin testing in drug-naïve patients, as it adds unnecessary cost, delay, and patient anxiety without clinical benefit, with a high strength of evidence based on clinical studies 1

The American Academy of Allergy, Asthma, and Immunology recommends that patients with a history of urticaria to cephalexin can receive amoxicillin without prior testing, and penicillin skin testing is not recommended unless the cephalosporin allergy history was anaphylaxis, angioedema, hypotension, or other severe IgE-mediated reactions 5
For patients with unverified penicillin allergy, the reaction rate to cephalosporins is less than 5%, making direct administration reasonable 5
If penicillin skin testing is performed and negative, a drug challenge to the penicillin is still advised, as recommended by the Journal of Allergy and Clinical Immunology 5
Penicillin delabeling, which involves penicillin skin testing followed by an oral amoxicillin challenge, can simplify all future beta-lactam administration recommendations 5

Immediate reactions to cephalexin manifest within minutes to 1-2 hours and include symptoms such as urticaria, angioedema, bronchospasm, hypotension, and anaphylaxis, according to the American Academy of Allergy, Asthma, and Immunology 6
Delayed reactions to cephalexin occur hours to several days after administration and typically present as maculopapular rashes, urticaria appearing after the immediate window, or other cutaneous manifestations, as reported by the American Academy of Allergy, Asthma, and Immunology 6
Patients with unverified or remote (>10 years) penicillin allergy histories have reaction rates to cephalosporins of less than 5%, with a linked probability of approximately 0.1%, as stated by the American Academy of Allergy, Asthma, and Immunology 6

Continue observation for delayed reactions over the subsequent 24-72 hours, particularly watching for cutaneous manifestations, as recommended by the American Academy of Allergy, Asthma, and Immunology 6